Abstract:Venous malformations (VMs) are the most common vascular developmental anomalies (birth defects). These defects are caused by developmental arrest of the venous system during various stages of embryogenesis. VMs remain a difficult diagnostic and therapeutic challenge due to the wide range of clinical presentations, unpredictable clinical course, erratic response to the treatment with high recurrence/persistence rates, high morbidity following nonspecific conventional treatment, and confusing terminology. The Consensus Panel reviewed the recent scientific literature up to the year 2013 to update a previous IUP Consensus (2009) on the same subject. ISSVA Classification with special merits for the differentiation between the congenital vascular malformation (CVM) and vascular tumors was reinforced with an additional review on syndrome-based classification. A "modified" Hamburg classification was adopted to emphasize the importance of extratruncular vs. truncular subtypes of VMs. This incorporated the embryological origin, morphological differences, unique characteristics, prognosis and recurrence rates of VMs based on this embryological classification. The definition and classification of VMs were strengthened with the addition of angiographic data that determines the hemodynamic characteristics, the anatomical pattern of draining veins and hence the risk of complication following sclerotherapy. The hemolymphatic malformations, a combined condition incorporating LMs and other CVMs, were illustratedas a separate topic to differentiate from isolated VMs and to rectify the existing confusion with namebased eponyms such as Klippel-Trenaunay syndrome. Contemporary concepts on VMs were updated with new data including genetic findings linked to the etiology of CVMs and chronic cerebrospinal venous insufficiency. Besides, newly established information on coagulopathy including the role of D-Dimer was thoroughly reviewed to provide guidelines on investigations and anticoagulation therapy in the management of VMs. Congenital vascular bone syndrome resulting in angio-osteo-hyper/hypotrophy and (lateral) marginal vein was separately reviewed. Background data on arterio-venous malformations was included to differentiate this anomaly from syndrome-based VMs. For the treatment, a new section on laser therapy and also a practical guideline for follow up assessment were added to strengthen the management principle of the multidisciplinary approach. All other therapeutic modalities were thoroughly updated to accommodate a changing concept through the years.

Molecular landscape of congenital vertebral malformations: recent discoveries and future directions

Molecular diagnosis of vertebral segmentation disorders in humans

Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans

Unraveling the Genetic Architecture of Congenital Vertebral Malformation with Reference to the Developing Spine

Genetic and Environmental Interaction in Malformation of the Vertebral Column

Progress and Perspective of TBX6 Gene in Congenital Vertebral Malformations

Core planar cell polarity genes VANGL1 and VANGL2 in predisposition to congenital vertebral malformations

Defective Somitogenesis and Abnormal Vertebral Segmentation in Man

Venous Malformations: Diagnosis, Management, and Future Directions

A Global Bibliometric and Visualization Analysis of Craniovertebral Junction Bony Abnormalities Based on VOSviewer and Citespace

Ventral body wall closure: Mechanistic insights from mouse models and translation to human pathology

Emerging pathogenic mechanisms in human brain arteriovenous malformations: a contemporary review in the multiomics era

Unraveling the Link of Altered TGFβ Signaling with Scoliotic Vertebral Malformations in Osteogenesis Imperfecta: A Comprehensive Review

Classification and Etiologic Dissection of Vertebral Segmentation Anomalies

The contribution of de novo coding mutations to meningomyelocele

Genetic mutations and phenotype characteristics in peripheral vascular malformations: A systematic review

The role of genetic and epigenetic factors in determining the risk of spinal fragility fractures: new insights in the management of spinal osteoporosis

Large-scale mouse mutagenesis identifies novel genes affecting vertebral development

Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013

Molecular mechanisms and therapeutic strategies for neuromuscular diseases

Molecular genetics of congenital heart disease